ProteoBridge
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $1.3M
Investors
- 1
About ProteoBridge
, Ltd. develops high-density protein microarrays and test kits for autoantibody validation. The technology researched by the company aims to develop a more accurate and comprehensive autoantibody detection method with a small amount of blood. As of 2022, Ryo Kumagai is the CEO of the company, which employs 12 employees. The company provides HuPEX™, which is a protein array with proteome-wide search capabilities that is focused on simulating the binding response that takes place in a biological organism. The firm offers technologies such as utilization of human cDNA clone resources, HuPEX™, proteome-wide protein synthesis technology, and protein array fabrication technology.
Who invested in ProteoBridge
1 investor across 1 round
See all investors in ProteoBridge
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 30, 2022
Amount
$1.3M
Investors
Questions about ProteoBridge
Who invested in ProteoBridge?
ProteoBridge has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ProteoBridge raised?
ProteoBridge has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ProteoBridge last raise money?
ProteoBridge's most recent round on record is a Series A, in Jun 2022.
What does ProteoBridge do?
ProteoBridge is a biotechnology company.
Where is ProteoBridge headquartered?
ProteoBridge is headquartered in Tokyo, Japan.
Which VCs invest in companies like ProteoBridge?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ProteoBridge's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ProteoBridge? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.